直肠癌新辅助治疗后原发肿瘤病理完全缓解者的外科治疗

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户:justle
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  目的:总结中、低位直肠癌新辅助治疗后原发肿瘤达病理完全缓解(pCR)者的临床病理特点,探讨合理的治疗措施。方法:回顾性分析1994年1月至2013年12月间,中国医学科学院肿瘤医院收治的局部晚期中、低位直肠癌经新辅助治疗后原发肿瘤达pCR的52例患者的临床资料,患者术前临床分期为Ⅱ期(cT3~4N0期)10例,Ⅲ期(cT3~4N+期)42例。
其他文献
Objective: The study aims to investigate the prevalence of, and factors influencing, preoperative anxiety and depression in gastric cancer patients in China.The results of this study will provide scie
Objective: PFTK1, also known as PFTAIRE1, CDK14, is a novel member of Cdc2-related serine/threonine protein kinases.Recent studies show that PFTK1 is highly expressed in several malignant tumors such
Objective: To identity specific long non-coding RNAs (lncRNAs) involved in distant metastasis of gastric cancer (GC).Method: Differentially expressed mRNAs and lncRNAs between stage Ⅳ and non-stage Ⅳ
Objective: To observe the clinical efficacy and adverse reactions of oxaliplatin combined with S-1 or gemcitabine as first-line chemotherapy for patients with biliary tract cancer.
Objective: The overall survival is poor for patients with thoracic esophageal cancer.The major reason is the high rate of lymph node metastases.However, recent studies found that the number of negativ
Objective: Genetic and epigenetic pathways are not independent in colorectal cancer (CRC) carcinogenesis.We aimed to determine the influence of various molecular features on Chinese patients colon can
Objective: This single-center, open-label, randomized, controlled trial aimed to evaluate the efficacy and safety of ginsenoside Rg3, a low toxicity vascular-endothelial growth factor (VEGF) inhibitor
目的:探讨立体定向放射治疗联合口服替吉奥(s-1)治疗晚期胰腺癌的疗效。方法:将83例晚期胰腺癌患者随机分立体定向放射治疗组和立体定向放射+替吉奥治疗组,分别观察不良反应和疗效。
目的: Bioinformatics analysis combined with metastasis-related genes microarray array showed that osteopontin could be important target genes of miR-29b.
目的:探讨CT、MR常规序列及扩散加权成像(diffusion-weighted imaging,DWI)对肝癌经导管动脉化疗栓塞术(transcatheter arterial chemoembolization,TACE)术后疗效的评估价值.方法:在西门子Espree 1.5T核磁机上对30例行TACE治疗的巨块型肝癌患者于术前24~48小时、术后24~48小时、术后14~16天、术后30~3